NARDUS HEALTHCARE LTD

Company Registration Number:
14088008 (England and Wales)

Unaudited statutory accounts for the year ended 31 May 2023

Period of accounts

Start date: 05 May 2022

End date: 31 May 2023

NARDUS HEALTHCARE LTD

Contents of the Financial Statements

for the Period Ended 31 May 2023

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Additional notes - 7
Balance sheet notes - 10

NARDUS HEALTHCARE LTD

Company Information

for the Period Ended 31 May 2023




Director: Bola Fatunwase
Aramide Foyinsola Olunowo
Synthia Rudo Sinyoro
Registered office: 101
Lockhurst Lane
Coventry
England
CV6 5SF
Company Registration Number: 14088008 (England and Wales)

NARDUS HEALTHCARE LTD

Profit and Loss Account

for the Period Ended 31 May 2023


Notes
13 months to
31 May 2023
£
Turnover 0
Gross Profit or (Loss) 0
Administrative Expenses ( 64,207 )
Operating Profit or (Loss) ( 64,207 )
Profit or (Loss) Before Tax ( 64,207 )
Profit or (Loss) for Period ( 64,207 )

The notes form part of these financial statements

NARDUS HEALTHCARE LTD

Balance sheet

As at 31 May 2023


Notes
13 months to
31 May 2023
£
Fixed assets
Tangible assets: 4 49,500
Total fixed assets: 49,500
Current assets
Cash at bank and in hand: 10,000
Total current assets: 10,000
Net current assets (liabilities): 10,000
Total assets less current liabilities: 59,500
Creditors: amounts falling due after more than one year: 5 ( 74,207 )
Total net assets (liabilities): ( 14,707 )

The notes form part of these financial statements

NARDUS HEALTHCARE LTD

Balance sheet continued

As at 31 May 2023


Notes
13 months to
31 May 2023
£
Capital and reserves
Called up share capital: 100
Profit and loss account: ( 14,807 )
Shareholders funds: ( 14,707 )

For the year ending 31 May 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 1 April 2024
And Signed On Behalf Of The Board By:

Name: Bola Fatunwase
Status: Director

The notes form part of these financial statements

NARDUS HEALTHCARE LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

NARDUS HEALTHCARE LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 2. Employees

    13 months to
    31 May 2023
    Average number of employees during the period 4

NARDUS HEALTHCARE LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 3. Off balance sheet disclosure

    No

NARDUS HEALTHCARE LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

4. Tangible assets

Fixtures & fittings Office equipment Total
Cost £ £ £
Additions 45,000 10,000 55,000
Disposals - - -
Revaluations - - -
Transfers - - -
At 31 May 2023 45,000 10,000 55,000
Depreciation
Charge for year 4,500 1,000 5,500
On disposals - - -
Other adjustments - - -
At 31 May 2023 4,500 1,000 5,500
Net book value
At 31 May 2023 40,500 9,000 49,500

NARDUS HEALTHCARE LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

5.Creditors: amounts falling due after more than one year

13 months to
31 May 2023
£
Other creditors 74,207
Total 74,207